MBRX logo

Moleculin Biotech (MBRX) Long Term Liabilities

Annual Total Long Term Liabilities

$5.33 M
+$4.92 M+1193.45%

December 31, 2023


Summary


Performance

MBRX Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMBRXbalance sheetmetrics:

Quarterly Long Term Liabilities

$10.32 M
+$8.20 M+385.97%

September 30, 2024


Summary


Performance

MBRX Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMBRXbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

MBRX Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1193.5%+168.1%
3 y3 years-36.2%+3422.9%
5 y5 years+271.4%+3422.9%

MBRX Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1193.5%at high+3422.9%
5 y5-year-36.2%+1193.5%-14.1%+3422.9%
alltimeall time-36.2%-100.0%-14.1%-100.0%

Moleculin Biotech Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$10.32 M(+386.0%)
Jun 2024
-
$2.12 M(-44.8%)
Mar 2024
-
$3.85 M(-27.8%)
Dec 2023
$5.33 M(+1193.4%)
$5.33 M(+972.2%)
Sep 2023
-
$497.00 K(+69.6%)
Jun 2023
-
$293.00 K(-15.3%)
Mar 2023
-
$346.00 K(-16.0%)
Dec 2022
$412.00 K(-72.1%)
$412.00 K(-30.5%)
Sep 2022
-
$593.00 K(-42.8%)
Jun 2022
-
$1.04 M(-20.4%)
Mar 2022
-
$1.30 M(-11.7%)
Dec 2021
$1.48 M(-82.3%)
$1.48 M(-61.1%)
Sep 2021
-
$3.79 M(-30.9%)
Jun 2021
-
$5.48 M(-18.0%)
Mar 2021
-
$6.69 M(-19.9%)
Dec 2020
$8.35 M
$8.35 M(-9.6%)
Sep 2020
-
$9.24 M(-23.1%)
Jun 2020
-
$12.01 M(+73.0%)
DateAnnualQuarterly
Mar 2020
-
$6.95 M(+14.0%)
Dec 2019
$6.09 M(+324.7%)
$6.09 M(+1904.6%)
Sep 2019
-
$304.00 K(+77.8%)
Jun 2019
-
$171.00 K(-5.0%)
Mar 2019
-
$180.00 K(-87.5%)
Dec 2018
$1.44 M(+856.7%)
$1.44 M(-48.8%)
Sep 2018
-
$2.80 M(-12.5%)
Jun 2018
-
$3.20 M(+25.1%)
Mar 2018
-
$2.56 M(+1606.7%)
Dec 2017
$150.00 K(+70.5%)
$150.00 K(0.0%)
Sep 2017
-
$150.00 K(0.0%)
Jun 2017
-
$150.00 K(-92.4%)
Mar 2017
-
$1.97 M(+2139.8%)
Dec 2016
$88.00 K(>+9900.0%)
$88.00 K(+76.0%)
Sep 2016
-
$50.00 K(-91.7%)
Jun 2016
-
$600.00 K(>+9900.0%)
Mar 2016
-
$0.00
Dec 2015
$0.00
-

FAQ

  • What is Moleculin Biotech annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Moleculin Biotech?
  • What is Moleculin Biotech annual total long term liabilities year-on-year change?
  • What is Moleculin Biotech quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Moleculin Biotech?
  • What is Moleculin Biotech quarterly long term liabilities year-on-year change?

What is Moleculin Biotech annual total long term liabilities?

The current annual total long term liabilities of MBRX is $5.33 M

What is the all time high annual total long term liabilities for Moleculin Biotech?

Moleculin Biotech all-time high annual total long term liabilities is $8.35 M

What is Moleculin Biotech annual total long term liabilities year-on-year change?

Over the past year, MBRX annual total long term liabilities has changed by +$4.92 M (+1193.45%)

What is Moleculin Biotech quarterly total long term liabilities?

The current quarterly long term liabilities of MBRX is $10.32 M

What is the all time high quarterly long term liabilities for Moleculin Biotech?

Moleculin Biotech all-time high quarterly total long term liabilities is $12.01 M

What is Moleculin Biotech quarterly long term liabilities year-on-year change?

Over the past year, MBRX quarterly total long term liabilities has changed by +$6.47 M (+168.10%)